BMO Capital lowered the firm’s price target on Accenture to $350 from $375 and keeps a Market Perform rating on the shares. The company’s Q3 earnings missed estimates, though it also delivered a solid bookings quarter against low expectations, while its Strategy & Consulting revenue growth turned positive thanks to contributions from M&A and generative AI, the analyst tells investors in a research note. BMO adds however that a more constructive stance would require the firm having greater confidence in Accenture’s FY25 organic growth.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACN: